Minowa Y

References (1)

Title : Effect of UGT1A1, CYP3A and CES Activities on the Pharmacokinetics of Irinotecan and its Metabolites in Patients with UGT1A1 Gene Polymorphisms - Yokokawa_2021_Eur.J.Drug.Metab.Pharmacokinet__

Author(s) : Yokokawa A , Kaneko S , Endo S , Minowa Y , Ayukawa H , Hirano R , Nagashima F , Naruge D , Okano N , Kobayashi T , Kawai K , Furuse J , Furuta T , Shibasaki H

Ref : Eur J Drug Metab Pharmacokinet , : , 2021

Abstract :

PubMedSearch : Yokokawa_2021_Eur.J.Drug.Metab.Pharmacokinet__

PubMedID: 33619631

Minowa Y

References (1)

1. Effect of UGT1A1, CYP3A and CES Activities on the Pharmacokinetics of Irinotecan and its Metabolites in Patients with UGT1A1 Gene Polymorphisms - Yokokawa_2021_Eur.J.Drug.Metab.Pharmacokinet__